An interventional study of Project EMPOWER and Being Brave Parent Education in Anxiety Disorders, sponsored by Massachusetts General Hospital. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-06.
Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 67 studies in Anxiety Disorders by Massachusetts General Hospital — 14 open to participants now, 20 under way, none of them phase 3. Anxiety Disorders · Massachusetts General Hospital.
Among the 67 studies in Anxiety Disorders by Massachusetts General Hospital, this one is the 24th largest by planned enrollment of the 64 interventional ones that give a count, is one of 4 that started in 2025, is one of 40 with no phase, reaches primary completion later than 12 of the 19 other live ones, and was the 62nd registered.
7,249 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.
Browse Anxiety Disorders studies →14 of the 67 studies in Anxiety Disorders by Massachusetts General Hospital are open now, in 2 countries. Recruiting first, the newest first:
Massachusetts General Hospital · Sites in United States
Ages 12–17
Massachusetts General Hospital · Sites in United States
Ages 7–17
Massachusetts General Hospital · Sites in United States
Ages 18–75
Massachusetts General Hospital · Sites in United States
Ages 18+ · Women only
Massachusetts General Hospital · Sites in United States
Ages 18–30
By country, each count listing its studies:
Of the 947 Anxiety Disorders studies recruiting now, 423 (45%) set no upper age limit and 455 (48%) stop at 75 or younger; 233 take children under 18; 319 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
67 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 9 · Phase 3 4 · Phase 4 11
First in 1998; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is above the median of 80 across 6,103 interventional studies indexed under Anxiety Disorders.
Median enrollment 63 across the 64 interventional studies, 123 across the 2 observational. Of the 44 that completed or were terminated, 27 (61%) have results posted.
This tab as a report to print or save as PDF → With an account.
Massachusetts General Hospital is the lead sponsor of 2,591 studies on the registry; 445 are open to participants now.
Of its 224 completed or terminated interventional studies of FDA-regulated products, 168 (75%) have results posted.
8 of the studies in Anxiety Disorders by Massachusetts General Hospital that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07639827Massachusetts General HospitalA Study of a Mental Fitness Intervention for Anesthesiology Resident Wellbeing and Self-Compassion | 2027-01 |
| NCT06226155Massachusetts General HospitalAdaptation of an Intervention Addressing Barriers to PrEP Use Among Pregnant Women in Zimbabwe | 2027-01-01 |
| NCT06316804Massachusetts General HospitalMobile Mental Health Stigma Reduction Intervention Among Black Adults | 2027-01-01 |
| NCT06654414Massachusetts General HospitalAdapting and Pilot Testing a Skills-based Smoking Cessation Intervention to Address Developmental and Health-related Stress Among Adults Who Smoke | 2027-03-31 |
| NCT06557005Massachusetts General HospitalFacilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions | 2027-05-23 |
Add all 8 to your calendar (.ics) → With an account.
Among the 67 studies in Anxiety Disorders by Massachusetts General Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The investigators are doing this research to test whether parents of children ages 2-7 can better manage their child's anxiety by completing a brief, online, self-guided parent education program. One way to provide anxiety management skills to more children, and to potentially prevent worsening outcomes, is to offer online and self-guided educational programs that parents can complete without a clinician. This randomized trial will evaluate the effects of two brief, online, self-guided parent education programs designed to improve parents' understanding of anxiety and teach parents way to help their children cope with anxiety. Parents will be randomly assigned to one of the three programs. The main aim of the study is to examine whether the parent programs, compared to an educational control reduce parental accommodation of anxiety across a 1-, 4-, and 8-month follow-up period. As a secondary aim, the investigators will explore whether the parent programs reduce children's anxiety symptoms over the 8-month follow-up period. Results will inform the development of a scalable, low-cost model for promoting access to evidence-based treatment to young children.
Anxiety disorders are very common in children, affecting as many as 30% by adolescence. Even 10% of preschool-age children are already affected. These disorders cause distress and can interfere with academic, social, and family functioning. There are very effective treatments for anxiety disorders, but, on average, kids suffer for four years between onset of their anxiety symptoms and proper diagnosis and treatment. Young children often do not receive treatment because pediatricians, parents, and teachers do not realize that treatment can benefit them and because there is a shortage of providers trained to provide mental health care to young children. Given the importance of early intervention, the investigators are interested in whether parents can learn to better manage their child's anxiety by completing a brief, online, and self-guided parent education program.
Parents will be randomized to one of three self-guided education programs: A three-session program with videos and a workbook and two single-session programs with activities. The programs teach parents how to promote brave behaviors in their child (rather than allowing the child to avoid situations that make them nervous). One of the three programs is considered a control condition, but all are education, and parents will not know whether they are in the control condition until after the 4-month evaluation when they will have the chance to be reassigned to one of the other conditions. The investigators predict that parents who receive one of the active programs, compared to the control, will report greater reductions in parental accommodation across 1-, 4-, and 8-month follow-up. As a secondary hypothesis, the investigators predict that children of parents who receive an active program will show improvements in anxiety symptoms across the 8 month study period.
Because the intervention strategies proposed are brief and easy-to-use, they could be easily implemented as part of routine practice, in much the same way as early intervention for other common childhood health conditions.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Parents will be eligible to participate if:
Exclusion Criteria:
Parents will be excluded if:
(1) Their child shows symptoms of suicidal or homicidal ideation, psychosis, or primary severe mood or behavior disorder (i.e., if treatment for another disorder other than anxiety is indicate prior to treatment for anxiety)
This program is a web-based, self-administered program for parents that takes about 20 minutes to complete. The program includes 5 elements based on the components of cognitive-behavioral therapy.
Behavioral: Project EMPOWER
This program is an online, self-guided program which consists of three brief video-recorded lessons (approximately 20 minutes each) with accompanying knowledge checks and workbook on implementing parent-directed cognitive-behavioral therapy.
Behavioral: Being Brave Parent Education
This program is an online, self-guided 20-minute program, that teaches parents about the importance of sharing feelings and about helpful versus unhelpful expression of emotion.
Behavioral: Sharing Feelings
Project EMPOWER is a web-based, self-administered program for parents that takes about 20 minutes to complete.
Being Brave Parent Education is an online, self-guided program which consists of three brief video-recorded lessons (approximately 20 minutes each) with accompanying knowledge checks and workbook on implementing parent-directed cognitive-behavioral therapy.
A self-guided 20-minute educational control, that teaches parents about the importance of sharing feelings and about helpful versus unhelpful expression of emotion.
Change in Pediatric Accommodation Scale, Parent-Report
The Pediatric Accommodation Scale is a parent-report of accommodation of their offspring's anxiety. Parents are asked to rate, on a 5-point scale from 0 (never) to 5 (always), the extent to which they accommodate their child's anxiety or avoidance behaviors. Total scores range from 0 to 25, with higher scores reflecting greater parental accommodation. Parents will report on their accommodation behaviors at baseline , 1-, 4-, and 8-months.
Time frame: Change over 8-month follow-up (Baseline to 1-month, 4-month, and 8-month follow-up)
Change in Child Anxiety Symptoms, Parent-Report Total T-Score
To assess child anxiety symptoms, parents will complete either the Spence Child Anxiety Scale (SCAS-P) for children ages 6-7, the Spence Preschool Anxiety Scale (SPAS) for children ages 3-5, or the Infant-Toddler Social and Emotional Assessment Scale (ITSEA) for children aged 2. Each measure produces a Total Anxiety T-Score, which will be used as the secondary outcome.
Time frame: Change over 8-month follow-up (Baseline to 1-month, 4-month, and 8-month follow-up)
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2025 (actual). Primary completion is estimated for Aug 2027, 23 months after the start.
Of 3,871 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 23 months is above that.
Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Massachusetts General Hospital →